Thomas Gidoin Joins OSE Immunotherapeutics as Chief Financial Officer
August 20, 2025 - 23:13
NANTES, France, August 20, 2025 – OSE Immunotherapeutics SA has officially announced the appointment of Thomas Gidoin as its new Chief Financial Officer. With over 15 years of extensive experience in capital markets and financial strategy, Gidoin brings a wealth of knowledge and expertise to the company’s Executive Committee.
Gidoin's background in biopharma finance is marked by a strong track record in strategic financial leadership, which he has demonstrated in both private and public sectors. His appointment is anticipated to enhance OSE Immunotherapeutics' financial governance and strategic initiatives, positioning the company for future growth and success.
The addition of Gidoin to the leadership team is seen as a pivotal move to strengthen the company's financial operations and align its strategies with the evolving landscape of the biopharmaceutical industry. Stakeholders and investors alike are looking forward to the insights and direction he will bring in his new role.
MORE NEWS
January 6, 2026 - 02:07
Cristina Riesgo Takes the Helm as Chief Financial Officer at VeralliaPARIS, January 05, 2026--Regulatory News: Verallia, a prominent player in the glass packaging industry, has announced the appointment of Cristina Riesgo as its new Chief Financial Officer,...
January 5, 2026 - 14:31
Evolution of Italy's Alternative Lending Market: Trends and Challenges AheadItaly`s alternative lending market is undergoing significant transformation, driven by the rapid growth of buy now, pay later (BNPL) services, private credit options, and the integration of...
December 31, 2025 - 03:27
Nacon Announces Release of 2025/26 Half-Year Financial ReportLesquin, December 30, 2025 - Nacon has officially announced the availability of its half-year financial report for the 2025/26 fiscal year. This report provides a comprehensive overview of the...
December 30, 2025 - 01:58
Strategies for Achieving Executive Alignment on AI InvestmentsIn an era where artificial intelligence (AI) is becoming integral to financial operations, organizations must prioritize executive alignment to ensure successful AI investments. Achieving this...